首页> 外文期刊>Der Pharmacia Lettre >Development and validation of related substances method for Varenicline and its impurities
【24h】

Development and validation of related substances method for Varenicline and its impurities

机译:缬氨酸及其杂质相关物质方法的建立与验证

获取原文
           

摘要

A simple and accurate reverse phase HPLC method has been developed and validated for quantification of Varenicline and its related impurities in bulk drug and pharmaceutical dosage form. Separation was achieved on c18 column by mobile phase consisted phosphate buffer with pH 3.0 and acetonitrile and flow rate 1.0ml/min. The detection wavelength was set at 235nm. The method was linear at concentration range from LOQ to 150% of specification level. The limit of quantification and limit of detection values less than 20% of specification level. Method precision and ruggedness the relative standard deviations did not exceed 2%. The accuracy of the method proved, the mean recovery between 85 to 115%. The results demonstrated that the method would have a great value when applied in quality control and stability studies for Verenicline.
机译:已经开发了一种简单而准确的反相HPLC方法,并已验证了该方法可用于定量散装药物和药物剂型中的Varenicline及其相关杂质。在c18色谱柱上通过流动相进行分离,该流动相由pH 3.0和乙腈,流速1.0ml / min的磷酸盐缓冲液组成。检测波长设定为235nm。该方法在LOQ至指定水平的150%浓度范围内是线性的。定量极限和检测值极限小于规格水平的20%。方法的精密度和耐用性相对标准偏差不超过2%。方法的准确性证明,平均回收率在85%至115%之间。结果表明,该方法在凡瑞尼克的质量控制和稳定性研究中具有重要的应用价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号